Efficiency of Therapeutic Plasma-Exchange in Acute Interstitial Lung Disease, Associated With Polymyositis/Dermatomyositis Resistant to Glucocorticoids and Immunosuppressive Drugs: A Retrospective Study
Interstitial lung disease (ILD) is a life-threating complication, commonly associated with polymyositis (PM), and dermatomyositis (DM). A subset of acute ILD associated with PM/DM patients are refractory to conventional treatment, and leads to a high rate of mortality. The efficacy of therapeutic pl...
Main Authors: | Yaogui Ning, Guomei Yang, Yuechi Sun, Shiju Chen, Yuan Liu, Guixiu Shi |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-11-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fmed.2019.00239/full |
Similar Items
-
The predictive prognostic factors for polymyositis/dermatomyositis-associated interstitial lung disease
by: Yumiko Sugiyama, et al.
Published: (2018-01-01) -
Tacrolimus in Patients With Interstitial Pneumonia Associated With Polymyositis or Dermatomyositis: Interim Report of Postmarketing Surveillance in Japan
by: Furuya, T., et al.
Published: (2022) -
Coadministration of tacrolimus with corticosteroid accelerates recovery in refractory patients with polymyositis/ dermatomyositis: a retrospective study
by: Shimojima Yasuhiro, et al.
Published: (2012-11-01) -
Polymyositis, Dermatomyositis, and Statins: A Review
by: Mauro Turrin
Published: (2018-12-01) -
Polymyositis and dermatomyositis: Disease spectrum and classification
by: Siba P Raychaudhuri, et al.
Published: (2012-01-01)